Santhera, SteinCares Sign Distribution Deal for Muscular Dystrophy Drug in Latin America, Caribbean

MT Newswires · 2d ago
01:49 AM EST, 11/12/2026 (MT Newswires) -- Santhera Pharmaceuticals (SANN.SW) selected SteinCares as a distribution partner for its Duchenne muscular dystrophy treatment Agamree, or vamorolone, in Latin America and the Caribbean. The agreement covers 31 countries across the region, with an initial focus on Brazil, where SteinCares will also seek regulatory approval, the Swiss specialty pharmaceutical company said Thursday. Under the agreement, Santhera will receive a percentage of net sales, in line with its previous distribution arrangements.